USTR Extends 81 Section 301 Exclusions for COVID Goods Until February
Exclusions from Section 301 China tariffs for 81 medical care products related to COVID-19 will be extended until the end of February 2023, the Office of the U.S. Trade Representative said in a pre-publication notice released Nov. 23. The exclusions had been set to expire Nov. 30.
“In light of the continuing efforts to combat COVID, the U.S. Trade Representative has determined that a 3 month extension of the 81 COVID related product exclusions is warranted,” USTR said in the notice.
The exclusions had originally been announced as a set of 99 exclusions, of which 81 were extended in November 2021 and June 2022. They are listed under U.S. Note 20(sss) to Subchapter III of Chapter 99 of the Harmonized Tariff Schedule of the U.S., and tariff subheading 9903.88.66.